Related references
Note: Only part of the references are listed.Targeted Brain Delivery of Rabies Virus Glycoprotein 29-Modified Deferoxamine-Loaded Nanoparticles Reverses Functional Deficits in Parkinsonian Mice
Linhao You et al.
ACS NANO (2018)
Nanogel-DFO conjugates as a model to investigate pharmacokinetics, biodistribution, and iron chelation in vivo
Yan Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
ROS-triggered degradable iron-chelating nanogels: Safely improving iron elimination in vivo
Zhi Liu et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Theranostic nanosystems for targeted cancer therapy
Homan Kang et al.
NANO TODAY (2018)
Iron Binding and Iron Removal Efficiency of Desferrioxamine Based Polymeric Iron Chelators: Influence of Molecular Size and Chelator Density
Jasmine L. Hamilton et al.
MACROMOLECULAR BIOSCIENCE (2017)
Restored iron transport by a small molecule promotes absorption and hemoglobinization in animals
Anthony S. Grillo et al.
SCIENCE (2017)
Renal clearable noble metal nanoparticles: photoluminescence, elimination, and biomedical applications
Jing Xu et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2017)
Nonabsorbable Iron Binding Polymers Prevent Dietary Iron Absorption for the Treatment of Iron Overload
Jian Qian et al.
ACS MACRO LETTERS (2017)
Enzymatically Biodegradable Polyrotaxane-Deferoxamine Conjugates for Iron Chelation
Zhi Liu et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
Renal Clearable Organic Nanocarriers for Bioimaging and Drug Delivery
Homan Kang et al.
ADVANCED MATERIALS (2016)
In vivo efficacy, toxicity and biodistribution of ultra-long circulating desferrioxamine based polymeric iron chelator
Jasmine L. Hamilton et al.
BIOMATERIALS (2016)
Iron distribution and histopathological study of the effects of deferoxamine and deferiprone in the kidneys of iron overloaded β-thalassemic mice
Paranee Yatmark et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2016)
Loss of divalent metal transporter 1 function promotes brain copper accumulation and increases impulsivity
Murui Han et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Pharmacokinetics, pharmacodynamics and toxicology of theranostic nanoparticles
Homan Kang et al.
NANOSCALE (2015)
The Antimicrobial Mechanism of Action of Epsilon- Poly-L-Lysine
Morten Hyldgaard et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2014)
Renal hemosiderosis and rapidly progressive glomerulonephritis associated with primary hemochromatosis
Sultan Ozkurt et al.
RENAL FAILURE (2014)
Central C-C bonding increases optical and chemical stability of NIR fluorophores
Hoon Hyun et al.
RSC ADVANCES (2014)
Design of Long Circulating Nontoxic Dendritic Polymers for the Removal of Iron in Vivo
Muhammad Imran ul-haq et al.
ACS NANO (2013)
His86 from the N-Terminus of Frataxin Coordinates Iron and Is Required for Fe-S Cluster Synthesis
Leslie E. Gentry et al.
BIOCHEMISTRY (2013)
Iron loading impairs lipoprotein lipase activity and promotes hypertriglyceridemia
Jonghan Kim et al.
FASEB JOURNAL (2013)
Synthesis and In Vivo Fate of Zwitterionic Near-Infrared Fluorophores
Hak Soo Choi et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
HFE Gene Variants Affect Iron in the Brain
Wint Nandar et al.
JOURNAL OF NUTRITION (2011)
Iron-Chelating Therapy for Transfusional Iron Overload
Gary M. Brittenham
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Hereditary hemochromatosis: patient experiences of the disease and phlebotomy treatment
Pierre Brissot et al.
TRANSFUSION (2011)
Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment
Antonello Pietrangelo
GASTROENTEROLOGY (2010)
Iron-Overload Cardiomyopathy: Pathophysiology, Diagnosis, and Treatment
Colm J. Murphy et al.
JOURNAL OF CARDIAC FAILURE (2010)
Design considerations for tumour-targeted nanoparticles
Hak Soo Choi et al.
NATURE NANOTECHNOLOGY (2010)
Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with beta-thalassaemia: the ESCALATOR study
Ali Taher et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Biomarkers of acute kidney injury
Charles L. Edelstein
ADVANCES IN CHRONIC KIDNEY DISEASE (2008)
Long-term experience with deferasirox (ICL670), a once-daily oral iron chelator, in the treatment of transfusional iron overload
M. D. Cappellini et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Renal clearance of quantum dots
Hak Soo Choi et al.
NATURE BIOTECHNOLOGY (2007)
Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator
Paul Harmatz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease
Elliott Vichinsky et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Extent of glomerular tubularization is an indicator of the severity of experimental acute kidney injury in mice
Jorge Isaac et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2007)
Iron binding dendrimers: A novel approach for the treatment of haemochromatosis
Tao Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major
C Borgna-Pignatti et al.
BLOOD (2006)
Oral chelators deferasirox and defefiprone for transfusional iron overload in thalassen a major: new data, new questions
EJ Neufeld
BLOOD (2006)
Hydroxamic acid-containing hydrogels for nonabsorbed iron chelation therapy: Synthesis, characterization, and biological evaluation
SC Polomoscanik et al.
BIOMACROMOLECULES (2005)
Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance
ZH Qi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Desferrioxamine related maculopathy: A case report
A Arora et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
Role of deferiprone in chelation therapy for transfusional iron overload
AV Hoffbrand et al.
BLOOD (2003)
Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis
XJ Zhou et al.
LABORATORY INVESTIGATION (2000)
First human studies with a high-molecular-weight iron chelator
PR Dragsten et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2000)